Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS [Phase 1, Phase 2]
An allogeneic transplant regimen using Mylotarg with fludarabine and melphalan was studied for acute myeloid leukemia, chronic myeloid leuke…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients
This update reports a completed clinical trial studying symptom-related cytokines in patients with acute myeloid leukemia and myelodysplasti…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes [Phase 2]
This is a completed Phase 2 clinical trial evaluating Gleevec (imatinib) in combination with low-dose cytarabine for elderly patients with a…
-
CLINICAL_TRIALS trial_result · 2012-08-01Clinical Trial Update: Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)
A completed clinical trial conducted at MD Anderson evaluated quality of life in patients with acute myeloid leukemia or myelodysplastic syn…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia [Phase 2]
Phase 2 trial evaluating peripheral stem cell transplantation with filgrastim in patients with acute or chronic myeloid leukemia; the study …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Feasibility Study of Acute Myelogenous Leukemia mRNA Plus Lysate Loaded Dendritic Cell Vaccines [Phase 1]
Phase 1 feasibility study evaluating an mRNA plus lysate loaded dendritic cell vaccine for acute myeloid leukemia; the trial has been termin…
-
CLINICAL_TRIALS trial_result · 2012-07-30Clinical Trial Update: Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 1]
A Phase 1 clinical trial evaluating the combination of cytarabine and UCN-01 in patients with refractory or relapsed acute myeloid leukemia …
-
CLINICAL_TRIALS trial_result · 2012-07-26Clinical Trial Update: Safety Study of IL-7 in Recipients of a Hemopoietic Stem Cell Transplant Peripheral Blood Stem Cell Transplant [Phase 1]
Phase 1 safety study of interleukin-7 in recipients of a hematopoietic stem cell transplant (peripheral blood) has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-24Clinical Trial Update: Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2, Phase 3]
This entry reports an update on a Phase 2/Phase 3 clinical trial of gemtuzumab ozogamicin in older patients with previously untreated acute …
-
CLINICAL_TRIALS trial_result · 2012-07-20Clinical Trial Update: Clofarabine, Cytarabine, and Idarubicin in Treating Patients With Intermediate-Risk or High-Risk Acute Myeloid Leukemia or High-Risk Myelodysplasia [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating a combination of clofarabine, cytarabine, and idarubicin in adults with intermediate- or high-risk acu…
-
CLINICAL_TRIALS trial_result · 2012-07-18Clinical Trial Update: Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052) [Phase 2]
Phase 2 trial evaluating temozolomide in previously untreated acute myeloid leukemia and myelodysplastic syndrome patients with low MGMT exp…
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome [Phase 2]
This is a Phase 2 clinical trial evaluating idarubicin, cytarabine, and gemtuzumab ozogamicin in patients with previously untreated high-ris…
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 trial evaluating gemtuzumab ozogamicin with or without chemotherapy in older patients with acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-16Clinical Trial Update: A Randomized Phase III Study of Intensive Consolidation With High Dose Cytosine Arabinoside in Acute Myelogenous Leukemia (AML-8B) [Phase 3]
Phase III randomized trial AML-8B evaluating intensive consolidation with high-dose cytarabine in acute myeloid leukemia has completed. The …
-
CLINICAL_TRIALS trial_result · 2012-07-13Clinical Trial Update: Phase I-II Study of Idarubicin, Cytarabine, and Sorafenib (BAY43-9006) [Phase 1, Phase 2]
Phase I/II trial evaluating idarubicin, cytarabine, and sorafenib in acute myeloid leukemia and related myeloid disorders; study completed w…
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: Therapeutic Effect and Safety Study of Decitabine in Elderly Acute Myeloid Leukemia Patients [Phase 3]
Phase 3 clinical trial evaluating decitabine for untreated adult acute myeloid leukemia in elderly patients, assessing therapeutic effect an…
-
CLINICAL_TRIALS trial_result · 2012-07-03Clinical Trial Update: A Phase 1 Dose-escalation Study to Evaluate the Safety and Pharmacokinetics (PK) of Palifermin in Subjects With Acute Leukemias Undergoing HSCT [Phase 1]
A Phase 1 dose-escalation study evaluating safety and pharmacokinetics of Palifermin in subjects with acute leukemia undergoing hematopoieti…
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia [Phase 3]
This Phase 3 trial compares combination chemotherapy with or without granulocyte colony-stimulating factor (G-CSF) in older patients with ac…
-
CLINICAL_TRIALS trial_result · 2012-07-02Clinical Trial Update: Interleukin-2 in Treating Patients With Relapsed or Refractory Acute Myelogenous Leukemia [Phase 2]
Phase 2 clinical trial evaluating interleukin-2 in relapsed or refractory acute myeloid leukemia has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-28Clinical Trial Update: Safety and Anti-Disease Activity of Oral Tosedostat (CHR-2797) in Elderly Subjects With Refractory or Relapsed AML [Phase 2]
Phase 2 clinical trial evaluating the safety and anti-disease activity of oral tosedostat (CHR-2797) in elderly patients with refractory or …
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Busulfan and Cyclophosphamide Followed by Bone Marrow Transplantation in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating conditioning with busulfan and cyclophosphamide followed by bone marrow transplantation in patients with acute myel…
-
CLINICAL_TRIALS trial_result · 2012-06-12Clinical Trial Update: Chemotherapy Plus Bone Marrow Transplantation and Filgrastim in Treating Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 trial update evaluating chemotherapy plus bone marrow transplantation with filgrastim in patients with acute myeloid leukemia or mye…
-
CLINICAL_TRIALS trial_result · 2012-06-11Clinical Trial Update: Arsenic Trioxide in Treating Patients With Acute Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial investigated arsenic trioxide in patients with acute myeloid leukemia and the study has completed.
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Unrelated Double Umbilical Cord Blood Units Transplantation [Phase 2, Phase 3]
Update on a Phase 2/3 trial evaluating unrelated double umbilical cord blood transplantation for acute and chronic leukemias, sponsored by T…
-
CLINICAL_TRIALS trial_result · 2012-05-15Clinical Trial Update: Busulfan and Fludarabine in Patients With AML and MDS [Phase 2]
Phase 2 trial evaluating a busulfan and fludarabine regimen in patients with acute myeloid leukemia and myelodysplastic syndrome has complet…